Published in Nephrol Dial Transplant on July 01, 1997
Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood (2006) 4.51
New insights into postrenal transplant hemolytic uremic syndrome. Nat Rev Nephrol (2010) 1.36
The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children. Pediatr Nephrol (2003) 1.06
Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome. Clin J Am Soc Nephrol (2008) 1.06
Complete factor H deficiency-associated atypical hemolytic uremic syndrome in a neonate. Pediatr Nephrol (2007) 1.05
Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis. Clin Exp Immunol (2007) 0.85
Atypical hemolytic uremic syndrome post-kidney transplantation: two case reports and review of the literature. Front Med (Lausanne) (2014) 0.77
Hemolytic uremic syndrome after renal transplantation. Hippokratia (2006) 0.76
Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome. Mol Cell (1998) 9.85
Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med (1998) 4.30
20 years or more of follow-up of living kidney donors. Lancet (1992) 3.88
Limiting financial disincentives in live organ donation: a rational solution to the kidney shortage. Am J Transplant (2006) 3.31
Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell (1991) 3.19
Pregnancy outcomes after kidney donation. Am J Transplant (2009) 2.66
Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations. Am J Hum Genet (1999) 2.44
Organ donation in three major American cities with large Latino and black populations. Transplantation (1988) 2.41
The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? Diabetes (2000) 2.41
Immunologic and nonimmunologic factors: different risks for cadaver and living donor transplantation. Transplantation (2000) 2.25
Does the noncompetitive NMDA receptor antagonist dizocilpine (MK801) really block behavioural sensitization associated with repeated drug administration? . Trends Pharmacol Sci (1998) 2.04
American Society of Transplant Surgeons transplant center outcomes requirements--a threat to innovation. Am J Transplant (2009) 2.00
Transplantation of discordant xenografts: a review of progress. Immunol Today (1990) 2.00
Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia (1996) 1.98
Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg (2001) 1.89
Pneumocystis carinii infection. Medicine (Baltimore) (1973) 1.79
Increased incidence of malignancy during chronic renal failure. Lancet (1975) 1.79
Are wound complications after a kidney transplant more common with modern immunosuppression? Transplantation (2001) 1.73
Bannayan-Riley-Ruvalcaba syndrome. Am J Med Genet (1992) 1.69
Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. Science (1976) 1.65
Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation (1995) 1.65
Long-term follow-up of living kidney donors: quality of life after donation. Transplantation (1999) 1.65
Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. Am J Transplant (2010) 1.65
Complications and risks of living donor nephrectomy. Transplantation (1997) 1.61
The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation (1994) 1.58
Morphologic changes induced by dilation of the pulmonary valve anulus with overlarge balloons in normal newborn lambs. Am J Cardiol (1985) 1.50
Glutamatergic mechanisms in addiction. Mol Psychiatry (2003) 1.49
Human factor H deficiency. Mutations in framework cysteine residues and block in H protein secretion and intracellular catabolism. J Biol Chem (1997) 1.48
Colon perforation after renal transplantation: a single-institution review. Clin Transplant (1997) 1.47
Successful transplantation after conversion of a positive crossmatch to negative by dissociation of IgM antibody. Transplantation (1989) 1.46
Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery (1977) 1.45
Selective retransplant after graft loss to nonadherence: success with a second chance. Am J Transplant (2009) 1.44
Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats. Behav Brain Res (2002) 1.42
2,500 living donor kidney transplants: a single-center experience. Ann Surg (2001) 1.41
First things first: laying the ethical and factual groundwork for living kidney donor selection standards. Am J Transplant (2008) 1.40
Uremic pericardial effusion. Treatment by catheter drainage and local nonabsorbable steroid administration. Nephron (1976) 1.39
Total or near total pancreatectomy and islet autotransplantation for treatment of chronic pancreatitis. Ann Surg (1980) 1.34
Health-related quality of life in kidney donors from the last five decades: results from the RELIVE study. Am J Transplant (2013) 1.34
Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria. Diabetes (1994) 1.33
Human islet autotransplantation following pancreatectomy. Transplant Proc (1979) 1.30
Pancreatic islet cell transplantation. Surg Clin North Am (1978) 1.28
An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group. Transplantation (1996) 1.27
Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies. Neurosci Biobehav Rev (1997) 1.27
Functional heterogeneity of the rat medial prefrontal cortex: effects of discrete subarea-specific lesions on drug-induced conditioned place preference and behavioural sensitization. Eur J Neurosci (1999) 1.27
Seven years' experience with antilymphoblast globulin for renal transplantation from cadaver donors. Ann Surg (1976) 1.26
Transplantation of pediatric donor kidneys to adult recipients. Is there a critical donor age? Ann Surg (1986) 1.26
Kidney, pancreas and liver allocation and distribution in the United States. Am J Transplant (2012) 1.24
Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation (1991) 1.24
Remodeling of renal interstitial and tubular lesions in pancreas transplant recipients. Kidney Int (2006) 1.24
Role of virus infections in immunosuppressed renal transplant patients. Transplant Proc (1973) 1.23
Functional relationship among medial prefrontal cortex, nucleus accumbens, and ventral tegmental area in locomotion and reward. Crit Rev Neurobiol (2000) 1.21
Short- and long-term outcomes of kidney transplants with multiple renal arteries. Ann Surg (1995) 1.21
The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007. Diabetologia (2008) 1.19
Effect of initial slow graft function on renal allograft rejection and survival. Clin Transplant (1997) 1.19
Demographic, metabolic, and blood pressure characteristics of living kidney donors spanning five decades. Am J Transplant (2012) 1.19
Risk factors for slow graft function after kidney transplants: a multivariate analysis. Clin Transplant (2002) 1.18
Human islet transplantation: a preliminary report. Transplant Proc (1977) 1.18
Sequential renal biopsies in insulin-dependent diabetic patients: structural factors associated with clinical progression. Kidney Int (1995) 1.17
Alport familial nephritis. Absence of 28 kilodalton non-collagenous monomers of type IV collagen in glomerular basement membrane. J Clin Invest (1987) 1.17
Pediatric renal transplants--results with sequential immunosuppression. Transplantation (1992) 1.16
Inflammation lesions in kidney transplant biopsies: association with survival is due to the underlying diseases. Am J Transplant (2011) 1.16
Proximal tubular basement membrane width in insulin-dependent diabetes mellitus. Kidney Int (1998) 1.15
The immunohistopathology of glomerular antigens. II. The glomerular basement membrane, actomyosin, and fibroblast surface antigens in normal, diseased, and transplanted human kidneys. Am J Pathol (1978) 1.14
Revisiting traditional risk factors for rejection and graft loss after kidney transplantation. Am J Transplant (2011) 1.14
Type IV collagen alpha 5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody. Am J Pathol (1994) 1.13
Pseudorejection: factors mimicking rejection in renal allograft recipients. Ann Surg (1977) 1.13
Autosomal dominant optic nerve colobomas, vesicoureteral reflux, and renal anomalies. Am J Med Genet (1995) 1.13
Maternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi. Ann Intern Med (1985) 1.13
Prolongation of cardiac xenograft survival by depletion of complement. Transplantation (1993) 1.13
ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation. Am J Transplant (2009) 1.13
Hepatocellular transplantation in acute liver failure. Surgery (1977) 1.12
Evolution of kidney, pancreas, and islet transplantation for patients with diabetes at the University of Minnesota. Am J Surg (1993) 1.12
Immunologic factors: the major risk for decreased long-term renal allograft survival. Transplantation (1999) 1.11
6-Hydroxydopamine lesion of the rat prefrontal cortex increases locomotor activity, impairs acquisition of delayed alternation tasks, but does not affect uninterrupted tasks in the radial maze. Behav Brain Res (1990) 1.11
Inherited factor H deficiency and collagen type III glomerulopathy. Pediatr Nephrol (1995) 1.09
Radiological case of the month. Coarctation of the aorta in Hurler syndrome. Arch Pediatr Adolesc Med (2000) 1.09
Chronic antigenic stimulation, herpesvirus infection, and cancer in transplant recipients. Lancet (1975) 1.09
Outcome of dialysis for acute renal failure in pediatric bone marrow transplant patients. Bone Marrow Transplant (1994) 1.08
Heterogeneous nature of microalbuminuria in NIDDM: studies of endothelial function and renal structure. Diabetologia (1998) 1.08
Post-transplant malignant lymphoma. Distinctive morphologic features related to its pathogenesis. Am J Med (1976) 1.08
Secondary (AA) amyloidosis in cystic fibrosis. A report of three cases. Am J Clin Pathol (1986) 1.07
Short-term culture of adult pancreatic fragments for purification and transplantation of islets of Langerhans. Surgery (1976) 1.07
Systemic lupus erythematosus within the first two decades of life. Am J Med (1977) 1.06
Sequential therapy--a prospective randomized trial of MALG versus OKT3 for prophylactic immunosuppression in cadaver renal allograft recipients. Transplantation (1992) 1.05
Pulmonary alveolar proteinosis: an uncommon cause of chronic neonatal respiratory distress. Am Rev Respir Dis (1980) 1.05
Distribution of integrin subunits in human diabetic kidneys. J Am Soc Nephrol (1996) 1.05
Recipient risk factors have an impact on technical failure and patient and graft survival rates in bladder-drained pancreas transplants. Transplantation (1994) 1.04
Hepatocellular transplantation for treatment of D-galactosamine-induced acute liver failure in rats. Transplant Proc (1979) 1.04
Renal transplantation in infants. Ann Surg (1990) 1.04
Structural involvement in type 1 and type 2 diabetic nephropathy. Diabetes Metab (2000) 1.03